Patrick A. Baeuerle
Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory BoardDr. Patrick A. Baeuerle, Ph.D., is Scientific Advisory Board Member of Crossbow Therapeutics, Inc. Dr. Patrick Baeuerle is a co-founder and Chief Scientific Advisor of Cullinan Oncology, as well as an Executive Partner at MPM BioImpact. He co-founded Crossbow Therapeutics and served as its interim Chief Scientific Officer (CSO), before transitioning to Crossbow’s Scientific Advisory Board, where he brings extensive immuno-oncology expertise. He started his career as a Professor and Chairman of Biochemistry and Molecular Biology at the Medical Faculty of Freiburg University (Germany), where he did groundbreaking research on transcription factor NFkB. Thereafter, he headed small-molecule drug discovery at Tularik, a publicly traded biotechnology company acquired by Amgen, before serving as CSO of Micromet and a Vice President of Research and General Manager at Amgen Research Munich GmbH. Dr. Baeuerle joined MPM Capital (now MPM BioImpact) in 2015, where he has co-founded eight oncology companies, namely Crossbow Therapeutics, Harpoon, TCR², iOmx, Maverick, Cullinan Oncology, Aktis Oncology and Werewolf. He is also an Honorary Professor of Immunology of the Medical Faculty of LMU in Munich (Germany) and is an elected member of the German National Academy of Sciences?Leopoldina. Dr. Baeuerle received his undergraduate diploma in biology from the University of Konstanz (Germany), holds a Ph.D. in Biology from the University of Munich (Germany) and performed post-doctoral research with Dr. David Baltimore at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT).
Positions
- Company NameCullinan Therapeutics, Inc.Stock CodeCGEMPositionCo-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
- Company NameAktis Oncology, Inc.Stock CodeAKTSPositionCo-Founder & Member of Scientific Advisory BoardColleagues
- TFTodd FoleyCo-Founder & Chairman
- MRMatthew RodenPresident, CEO & Director
- PLPaul L. FeldmanChief Scientific Officer
- ACAkos CzibereChief Medical Officer
- PAPatrick A. BaeuerleCo-Founder & Member of Scientific Advisory Board
- KHKen HerrmannChair of Scientific Advisory Board & Independent Director
- MTMary T. ThistleIndependent Director
